What's new

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Feb 19, 2025 - 14:12
 0
Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Remote blood sample collector maker YourBio Health revamps leadership team

Next Article

Finding clinical trials with the ACT EU Trial Map, Online, European Medicines Ag...

Related Posts

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+V), Online, from 27 March 2025, 12:30 (CET) to 27 March 2025, 13:00 (CET)

Certificates Processing System: Demo & Q&A session for ...

Feb 28, 2025  0

Herbal medicinal product: Tribuli terrestris herbaArray, D: Draft under discussion

Herbal medicinal product: Tribuli terrestris herbaArray...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0